Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study
Sarah H. Lisanby, Shawn M. McClintock, W. Vaughn McCall, Rebecca G. Knapp, C. Munro Cullum, Martina Mueller, Zhi‐De Deng, Abeba A. Teklehaimanot, Matthew V. Rudorfer, Elisabeth Bernhardt, George S. Alexopoulos, Samuel H. Bailine, Mimi C. Briggs, Emma T. Geduldig, Robert M. Greenberg, Mustafa M. Husain, Styliani Kaliora, Vassilios Latoussakis, Lauren S. Liebman, Georgios Petrides, Joan Prudic, Peter B. Rosenquist, Shirlene Sampson, Kristen G. Tobias, Richard D. Weiner, Robert C. Young, Charles H. Kellner
Topics & Concepts
NeurocognitivePharmacotherapyElectroconvulsive therapyPsychologyLate life depressionMajor depressive disorderVenlafaxinePsychiatryDepression (economics)Verbal fluency testMoodNeuropsychologyMedicinePediatricsClinical psychologyCognitionAntidepressantAnxietyMacroeconomicsEconomicsElectroconvulsive Therapy StudiesTreatment of Major DepressionTranscranial Magnetic Stimulation Studies